中财网 中财网股票行情
昭衍新药(603127)财务分析指标    年份：
截止日期2024-12-312024-09-302024-06-302024-03-312023-12-31
营业总收入(万元)201833.38133515.6184935.6532480.91237648.68
营业收入(万元)201833.38133515.6184935.6532480.91237648.68
营业总成本(万元)176374.83122773.4380644.3029329.46162201.02
营业成本(万元)144456.0296825.1659142.3421815.70136370.11
净利润(万元)2303.43-7516.63-16671.77-27135.8740195.33
归属于母公司的净利润(万元)7407.54-7030.71-16974.26-27222.2539699.26
营业利润(万元)10434.73-6966.10-17715.47-29300.8350709.63
利润总额(万元)10403.91-6989.23-17735.11-29313.0050695.04
少数股东损益(万元)-432.03-393.69-249.57-114.11-544.00
基本每股收益(元)0.10(元)-0.09(元)-0.23(元)-0.36(元)0.53(元)
稀释每股收益(元)0.10(元)-0.09(元)-0.23(元)-0.36(元)0.53(元)
非经常性损益(万元)----2865.23----
扣除非经常性损益后净利润(万元)2357.34-11346.82-19839.49-28066.6733756.47
总资产(万元)939615.26952518.48966127.37973325.451002715.96
总负债(万元)131696.44153435.02174603.23173952.63174611.92
归属于母公司股东权益合计(万元)807881.86800243.57791601.24799314.46827931.57
股东权益合计(万元)807918.83799083.46791524.14799372.82828104.04
实收资本(股本)(万元)74947.7374947.7374988.8774988.8774988.87
资本公积(万元)523766.59525002.00526712.82526712.82526712.82
未分配利润(万元)209496.91197412.01187425.19189174.90216397.15
经营活动产生的现金流量净额(万元)33892.8719232.5715771.6611995.3562287.51
经营活动现金流入小计(万元)181138.70136769.1491913.9449259.00243330.65
经营活动现金流出小计(万元)147245.83117536.5776142.2737263.64181043.14
投资活动产生的现金流量净额(万元)-196302.40-95005.08-74567.20-6756.23-31542.95
投资活动现金流入小计(万元)336550.20250809.81191448.6111145.3562390.31
投资活动现金流出小计(万元)532852.60345814.89266015.8117901.5893933.26
筹资活动产生的现金流量净额(万元)-26562.75-24882.81-10725.03-3792.84-36167.79
筹资活动现金流入小计(万元)----------
筹资活动现金流出小计(万元)26562.7524882.8110725.033792.8436167.79
期末现金及现金等价物余额(万元)96520.31184012.45215819.51286531.42285364.70
最后修改日期2025-03-282024-10-312024-09-022024-04-292024-03-28
↑返回页顶↑

转至昭衍新药（603127）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。